Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.99 USD | -1.27% |
|
-6.41% | -63.18% |
06-04 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
05-31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-63.18% | 1.79B | |
+15.77% | 121B | |
+19.56% | 113B | |
+17.47% | 26.02B | |
-25.23% | 19.39B | |
-19.51% | 15.91B | |
-19.02% | 15.09B | |
-46.87% | 15.06B | |
+63.87% | 14.93B | |
+5.64% | 13.85B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- JMP Securities Adjusts Inhibrx Price Target to $27 From $35, Maintains Market Outperform Rating